TGFB1 represses xCT expression via Smad3 activation and mildly increases lipid peroxidation, making HCC cells sensitive to GPX4 inhibition, which means TGFB1 raises ferroptosis risk (Kim et al., 2020). The gene discussed is GPX4; the disease is hepatocellular carcinoma.